Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.1 (
Mg2+-ATPase
)
1,484
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Gentamicin and neomycin-resistant mutants of Escherichia coli K-12 were isolated some of which were resistant to nitrofurans, chlorate, P1 and lambda bacteriophages as well as to all aminoglycoside antibiotics tested. Previously isolated nitrofuran-resistant mutants were not cross-resistant to the tested aminoglycosides, chlorate and bacteriophages. The aminoglycoside-resistant mutants exhibiting cross-resistance had enhanced membrane
Mg2+-ATPase
and decreased periplasmic alkaline phosphatase activity compared to their parent sensitive strains. The mutants were also defective in the fermentation of sugars, reduction of nitrate and nitrite, and in
formate dehydrogenase
activity. Preliminary genetic studies indicated that the pleiotropic mutation might be located in the upper left quadrant of the E. coli K-12 chromosome linkage map. It is postulated that such mutants with gross membrane alterations have impaired accumulation of aminoglycoside and nitrofuran antibiotics.
...
PMID:Gentamicin- and neomycin-resistant mutants of Escherichia coli K-12 cross-resistant to nitrofurans. 614 38